ACE EduTremd (BSE 530093)₹3.700.00%Education
In the Jun 2026 quarter (standalone), ACE EduTremd reported sales of ₹0.04 Cr and net profit of ₹0 Cr. For the year to Mar 2026, sales were ₹0 Cr and net profit −₹0.15 Cr.
Company filings, standalone accounts; latest reported quarter Jun 2026
| Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.04 |
| Expenses | 0.02 | 0.08 | 0.03 | 0.03 | 0.37 | 0.20 | 0.04 | 0.06 | 0.03 | 0.13 | 0.04 | 0.03 |
| Operating Profit | 0.00 | −0.06 | −0.01 | −0.01 | −0.35 | −0.18 | −0.02 | −0.04 | −0.01 | −0.11 | −0.02 | 0.00 |
| OPM % | — | — | — | — | — | — | — | — | — | — | — | 33.3% |
| Other Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | 0.00 | −0.06 | −0.01 | −0.01 | −0.35 | −0.18 | −0.02 | −0.04 | −0.01 | −0.11 | −0.02 | 0.00 |
| Tax % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net Profit | 0.00 | −0.06 | −0.01 | −0.01 | −0.35 | −0.18 | −0.02 | −0.04 | −0.01 | −0.11 | −0.02 | 0.00 |
| EPS (Rs) | −0.02 | −0.09 | −0.03 | −0.03 | −0.40 | −0.22 | −0.04 | −0.06 | −0.03 | −0.14 | −0.04 | 0.02 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 15.35 | 8.75 | 2.76 | 0.56 | 0.28 | 0.13 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.04 |
| Expenses | 12.50 | 6.89 | 1.63 | 0.49 | 0.17 | 0.08 | 0.12 | 0.08 | 0.06 | 0.61 | 0.11 | 0.23 |
| Operating Profit | 2.85 | 1.85 | 1.12 | 0.06 | 0.10 | 0.04 | −0.10 | −0.06 | −0.04 | −0.59 | −0.09 | −0.14 |
| OPM % | 18.6% | 21.2% | 41.0% | 12.7% | 40.7% | 41.6% | — | — | — | — | — | −350.0% |
| Other Income | 0.00 | 0.00 | 0.00 | 0.08 | 0.08 | 0.07 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 3.80 | 2.67 | 1.41 | 0.84 | 0.56 | 0.40 | 0.29 | 0.05 | 0.04 | 0.00 | 0.00 | 0.00 |
| Profit before tax | −0.94 | −0.81 | −0.28 | −0.70 | −0.38 | −0.29 | −0.40 | −0.12 | −0.09 | −0.59 | −0.09 | −0.14 |
| Tax % | −31.6% | −30.5% | 210.3% | −29.6% | 35.9% | 6.7% | 7.3% | 53.8% | 60.0% | 11.7% | 60.0% | — |
| Net Profit | −0.65 | −0.56 | −0.89 | −0.50 | −0.53 | −0.31 | −0.43 | −0.19 | −0.15 | −0.65 | −0.15 | −0.14 |
| EPS (Rs) | −0.73 | −0.63 | −0.99 | −0.57 | −0.60 | −0.34 | −0.49 | −0.23 | −0.18 | −0.73 | −0.18 | −0.19 |
| Dividend payout % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 9.15 | 9.14 | 9.14 | 9.15 | 9.13 | 9.13 | 9.13 | 9.15 | 9.14 | 9.15 | 9.15 | 9.15 |
| Reserves | 3.91 | 3.24 | 2.68 | 1.77 | 1.26 | 0.73 | 0.40 | −0.05 | −0.25 | −0.41 | −1.08 | −1.24 |
| Borrowings | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Liabilities | 4.07 | 3.41 | 3.56 | 4.01 | 4.41 | 4.56 | 4.06 | 4.06 | 4.05 | 3.81 | 4.42 | 4.51 |
| Total Liabilities | 17.13 | 15.79 | 15.38 | 14.93 | 14.80 | 14.42 | 13.59 | 13.16 | 12.94 | 12.55 | 12.49 | 12.42 |
| Fixed Assets | 8.27 | 7.31 | 4.64 | 3.23 | 2.38 | 1.80 | 1.40 | 1.09 | 1.03 | 0.98 | 0.98 | 0.98 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 8.86 | 8.48 | 10.74 | 11.70 | 12.42 | 12.62 | 12.19 | 12.07 | 11.91 | 11.57 | 11.51 | 11.44 |
| Trade receivables | 0.00 | 0.00 | 1.97 | 4.66 | 5.22 | 5.48 | 5.49 | 5.49 | 5.48 | 5.48 | 5.48 | 5.49 |
| Cash & equivalents | 0.12 | 0.05 | 0.04 | 0.02 | 0.02 | 0.02 | 0.02 | 0.06 | 0.02 | 0.03 | 0.02 | 0.02 |
| Total Assets | 17.13 | 15.79 | 15.38 | 14.93 | 14.80 | 14.42 | 13.59 | 13.16 | 12.94 | 12.55 | 12.49 | 12.42 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | 4.25 | 2.80 | −0.02 | −0.02 | −0.02 | −0.02 | 0.05 | −0.06 | 0.03 | −0.02 |
| Cash from investing activity | −4.16 | −2.84 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash from financing activity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net cash flow | 0.09 | −0.08 | −0.02 | −0.03 | −0.03 | −0.03 | 0.05 | −0.06 | 0.03 | −0.02 |
| Capex | 4.16 | 2.84 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Free cash flow | 0.08 | −0.07 | −0.03 | −0.03 | −0.03 | −0.03 | 0.05 | −0.06 | 0.03 | −0.02 |
| CFO / OP % | 109.0% | 99.0% | 0.0% | 0.0% | 0.0% | 0.0% | −36.0% | 70.9% | −40.0% | 2.0% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 0 | 0 | 83 | 618 | 3,459 | 7,396 | 16,639 | — | — | — | — | — |
| Cash conversion cycle | 0 | 0 | 81 | 616 | 3,457 | 7,394 | 16,637 | — | — | — | — | — |
| Working capital days | −60 | −81 | −66 | 91 | 556 | 1,310 | 4,440 | — | — | — | — | — |
| ROCE % | −4.0% | −7.5% | −6.8% | −2.6% | −6.7% | −3.9% | −3.1% | −4.4% | −1.5% | −1.1% | −7.2% | −1.3% |
For the Jun 2026 quarter, ACE EduTremd reported sales of ₹0.04 Cr and net profit of ₹0 Cr. The operating margin was 33.3%.
ACE EduTremd's sales for the year to Mar 2026 were ₹0 Cr; over the last twelve months they were ₹0.04 Cr.
Net profit for the year to Mar 2026 was −₹0.15 Cr, and −₹0.14 Cr over the last twelve months. Earnings per share over the same trailing period were ₹−0.19.
ACE EduTremd reported borrowings of ₹0 Cr at Mar 2026, against cash and equivalents of ₹0.02 Cr.
Cash from operations was −₹0.02 Cr in the year to Mar 2025; after capital spending, free cash flow was −₹0.02 Cr.